Diabetes Research and Clinical Practice
Volume 86, Issue 3 , Pages 247-253, December 2009

Glibenclamide-related excess in total and cardiovascular mortality risks: Data from large Ukrainian observational cohort study

V.P. Komisarenko Institute of Endocrinology and Metabolism, Vishgorodska 69, 04114 Kiev, Ukraine

Received 3 March 2009; received in revised form 24 August 2009; accepted 8 September 2009. published online 05 October 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0168-8227(09)00380-5

doi:10.1016/j.diabres.2009.09.008

Diabetes Research and Clinical Practice
Volume 86, Issue 3 , Pages 247-253, December 2009